MediWound Ltd.

NASDAQ:MDWD

Biotechnology

Healthcare
$13.61 -0.60%

-$0.09 today

Market cap
$175.71M
Beta
0.15
P/E (TTM)
-7.0
EPS (TTM)
-$2.03
52W Low $13.54High $21.26

Volume 0.17M

Average 0.09M

MDWD Other Financing Activities

Financing cash flows not reported separately.

MediWound Ltd.NASDAQ: MDWD

Other Financing Activities · Q1 FY2026 · quarter ended Mar 2026

Other financing activities growth accelerates

Q1 FY2026 other financing activities of $421K (cash outflow) rose 269.3% year over year, ahead of the -28.5% change in trailing-twelve-month other financing activities. Sequentially, it rose 23.9% from the prior quarter. Over 3 fiscal years it compounded at -18.3% a year.

Context

  • Other financing activities amounted to 8.4% of revenue in FY2025, down 0.7 pp from a year earlier.
  • Other financing activities grew in size in 0 of the last 3 fiscal years.
  • FY2025 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +269.3% holds above the trailing-twelve-month pace of -28.5%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$421K+23.9% QoQ
Last fiscal yearDec 2025
-$1.43M-22.6% YoY
LTMMar 2026
-$1.25M-28.5% YoY
Other Financing Activities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+269.3%——
1 year-22.6%——
3-year CAGR-18.3%——
5-year CAGR——
10-year CAGR——

Other Financing Activities history

USD · from the cash flow

Latest · FY2025
(1.43M) USD
Year-over-year change
+22.6%

Other Financing Activities vs competitors

How MDWD compares with its peers on the latest reported figures

  • Peers report in different currencies, so other financing activities is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -28.5% is the 3rd highest of 9, against a peer median of -99.8%.
  • Other financing activities amounts to 8.6% of revenue for MDWD, versus a peer median of 4.3%.
MDWD Competitors
Other Financing Activities for MDWD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MDWDMediWound Ltd.LTM Mar 2026$1.25M USD-28.5%-18.3%8.6%
OBIOOrchestra BioMed Holdings, Inc.LTM Mar 2026$1.09M USD-26.8%-46.5%3.3%
SLSSELLAS Life Sciences Group, Inc.LTM Sep 2026$461K USD+631.7%——
TARAProtara Therapeutics, Inc.LTM Mar 2026$272K USD-107.7%——
IVAInventiva S.A.FY2025€236.98K EUR-99.7%—5.3%
IVVDInvivyd, Inc.LTM Mar 2026$220K USD-460.7%—0.4%
RNACCartesian Therapeutics, Inc.LTM Mar 2026$170K USD-100.1%—9.6%
EPRXEupraxia Pharmaceuticals Inc.LTM Mar 2026$4.86K USD-81.2%——
NTHINeonc Technologies Holdings, Inc.LTM Mar 2026$0 USD———
AARDAardvark Therapeutics, Inc. Common StockLTM Mar 2026$0 USD-100.0%——
Peer median (excluding MDWD) —-99.8%-46.5%4.3%

Competitors are the stored peer set for MDWD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(13.55M)(19.6M)(6.72M)(30.22M)(23.88M)
Depreciation & Amortization1.24M1.27M1.3M1.48M1.71M
Deferred Income Tax(124K)0000
Stock-Based Compensation1.67M1.95M1.94M3.14M3.11M
Change in Working Capital162K(7.24M)2.34M1.27M4.77M
Accounts Receivables929K(7.58M)4.76M(1.02M)4.88M
Inventory257K(721K)(906K)187K(1.36M)
Accounts Payables1.72M414K(594K)406K2.35M
Other Working Capital(2.75M)645K(928K)1.7M(1.1M)
Other Non-Cash Items1.69M11.74M(9.33M)10.71M(236K)
Operating Cash Flow(8.92M)(11.89M)(10.47M)(13.62M)(14.53M)
Capital Expenditures(489K)(555K)(6.46M)(6.27M)(5.51M)
Acquisitions (Net)00000
Purchases of Investments0000(14.04M)
Sales of Investments4M0000
Other Investing Activities35K74K(27.86M)(2.12M)0
Investing Cash Flow3.55M(481K)(34.32M)(8.4M)(19.54M)
Debt Repayment000(928K)0
Common Stock Issued3K38.38M24.91M22.17M31.05M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(1.05M)(2.62M)(1.99M)(1.84M)(1.43M)
Financing Cash Flow(1.05M)35.76M22.92M19.39M29.62M
Effect of Forex Changes88K(549K)(160K)(84K)95K
Net Change in Cash(6.33M)22.85M(22.03M)(2.71M)(4.36M)
Free Cash Flow(9.41M)(12.44M)(16.93M)(19.9M)(20.04M)

MediWound Ltd.

NASDAQ:MDWD

Intrinsic Alpha fair value

Locked

Current Price

$13.61

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.